Adenosine, bridging chronic inflammation and tumor growth
Adenosine (Ado) is a well-known immunosuppressive agent that may be released or generated extracellularly by cells, via degrading ATP by the sequential actions of the ectonucleotides CD39 and CD73. During inflammation Ado is produced by leukocytes and tissue cells by different means to initiate the...
Main Authors: | Luxia Chen, Mohamad Alabdullah, Karsten Mahnke |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1258637/full |
Similar Items
-
Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury
by: Xiangyun Li, et al.
Published: (2021-01-01) -
Adenosine and Inflammation: Here, There and Everywhere
by: Silvia Pasquini, et al.
Published: (2021-07-01) -
Role of Hypoxia and the Adenosine System in Immune Evasion and Prognosis of Patients with Brain Metastases of Melanoma: A Multiplex Whole Slide Immunofluorescence Study
by: Arnulf Mayer, et al.
Published: (2020-12-01) -
Hypoxia-adenosine axis as therapeutic targets for acute respiratory distress syndrome
by: Katherine Figarella, et al.
Published: (2024-01-01) -
Extracellular adenosine-mediated modulation of regulatory T cells
by: Akio eOhta, et al.
Published: (2014-07-01)